Related references
Note: Only part of the references are listed.Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine
Seung E. Cha et al.
ONCOIMMUNOLOGY (2021)
A review of bispecific antibodies and antibody constructs in oncology and clinical challenges
Frans V. Suurs et al.
PHARMACOLOGY & THERAPEUTICS (2019)
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
Reyes Gonzalez-Exposito et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Antibody-Oligonucleotide Conjugates as Therapeutic, Imaging, and Detection Agents
Igor Dovgan et al.
BIOCONJUGATE CHEMISTRY (2019)
Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Engineering therapeutic bispecific antibodies using CrossMab technology
Christian Klein et al.
METHODS (2019)
Click Chemistry as a Tool for Cell Engineering and Drug Delivery
Yukiya Takayama et al.
MOLECULES (2019)
A Review of the Role of Carcinoembryonic Antigen in Clinical Practice
Claire Hall et al.
ANNALS OF COLOPROCTOLOGY (2019)
Bispecific antibody based therapeutics: Strengths and challenges
Archana Thakur et al.
BLOOD REVIEWS (2018)
Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
Raffaella Rossin et al.
NATURE COMMUNICATIONS (2018)
Target-induced click conjugation for attomolar electronic monitoring of Cu(II) using horseradish peroxidase as indicator and nanogold particles as enhancer
Jing Lv et al.
ANALYTICAL METHODS (2017)
The growing world of CAR T cell trials: a systematic review
Astrid Holzinger et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors
Marina Bacac et al.
CLINICAL CANCER RESEARCH (2016)
Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications
Min Zhu et al.
CLINICAL PHARMACOKINETICS (2016)
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Arend von Stackelberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Click-Conjugation of Nanogold-Functionalized PAMAM Dendrimer: Toward a Novel Electrochemical Detection Platform
Ying Tang et al.
ELECTROANALYSIS (2015)
Hairpin DNA-Dependent Click Conjugation of Oligonucleotides for Electrochemical Monitoring of Copper(II)
Dianyong Tang et al.
ELECTROANALYSIS (2015)
Systematic and site-specific analysis of N-sialoglycosylated proteins on the cell surface by integrating click chemistry and MS-based proteomics
Weixuan Chen et al.
CHEMICAL SCIENCE (2015)
CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas
Michael D. Oberst et al.
MABS (2014)
Bispecific antibodies rise again
Ken Garber
NATURE REVIEWS DRUG DISCOVERY (2014)
Imaging Cell Surface Glycosylation in Vivo Using Double Click Chemistry
Andre A. Neves et al.
BIOCONJUGATE CHEMISTRY (2013)
Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies
Ian M. Zitron et al.
BMC CANCER (2013)
A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels-Alder Click Chemistry
Brian M. Zeglis et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
DNA-Based Hybridization Chain Reaction for Amplified Bioelectronic Signal and Ultrasensitive Detection of Proteins
Bing Zhang et al.
ANALYTICAL CHEMISTRY (2012)
The CEA/CD3-Bispecific Antibody MEDI-565 (MT111) Binds a Nonlinear Epitope in the Full-Length but Not a Short Splice Variant of CEA
Li Peng et al.
PLOS ONE (2012)
In Vivo Chemistry for Pretargeted Tumor Imaging in Live Mice
Raffaella Rossin et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Affinity and Avidity in Antibody-Based Tumor Targeting
Stephen I. Rudnick et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Effect of PEGylation on the solution conformation of antibody fragments
Yanling Lu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: A preclinical study
JK Chan et al.
CLINICAL CANCER RESEARCH (2006)
Anti-CD3 x anti-epidermal growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to EGFR-positive cancers in vitro and in an animal model
U Reusch et al.
CLINICAL CANCER RESEARCH (2006)
T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro
JM Gall et al.
EXPERIMENTAL HEMATOLOGY (2005)
Chemical remodelling of cell surfaces in living animals
JA Prescher et al.
NATURE (2004)
Humanization of the anti-CEA T84.66 antibody based on crystal structure data
PJ Yazaki et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Share Paper
